The genetic architecture of Parkinson disease in Spain: characterizing population-specific risk, differential haplotype structures, and providing etiologic insight
暂无分享,去创建一个
Sonja W. Scholz | D. Hernandez | M. Nalls | A. Singleton | J. Hoenicka | C. Blauwendraat | E. Tolosa | J. Kulisevsky | F. Valldeoriola | J. López-Sendón | V. Álvarez | J. Clarimón | P. Pástor | E. Muñoz | M. Marti | S. Scholz | J. Simón‐Sánchez | J. R. Gibbs | H. Morris | J. Brooks | C. Clarke | K. Morrison | J. Botía | J. Infante | C. Dalgard | A. López de Munain | J. Marín-Lahoz | B. Pascual-Sedano | J. Pagonabarraga | M. Aguilar | I. Álvarez | M. Diez-Fairen | Oriol Dols-Icardo | M. Menéndez-González | S. Bandres-Ciga | Sarah Ahmed | M. Sabir | A. Adarmes-Gómez | Inmaculada Bernal-Bernal | D. Buiza-Rueda | F. Carrillo | M. Carrión-Claro | P. Gómez-Garre | S. Jesús | M. Labrador-Espinosa | D. Macias | Carlota Méndez-del-Barrio | T. Periñán-Tocino | Cristina Tejera-Parrado | Laura Vargas-González | J. P. Tartari | M. Buongiorno | A. Gorostidi | J. Bergareche | E. Mondragón | A. Vinagre-Aragón | I. Croitoru | J. Ruiz‐Martinez | M. Ezquerra | A. Cámara | Y. Compta | Manel Fernández | R. Fernández-Santiago | I. González-Aramburu | A. Sánchez Rodríguez | M. Sierra | M. Blázquez | C. García | E. Suarez-San Martin | P. García-Ruiz | J. C. Martínez‐Castrillo | L. Vela-Desojo | C. Ruz | F. Barrero | F. Escamilla-Sevilla | A. Mínguez-Castellanos | D. Cerdán | C. Tabernero | M. J. Gomez Heredia | F. Pérez Errazquin | M. Romero-Acebal | C. Feliz | M. Mata | Irene Martínez Torres | Jonggeol J. Kim | S. Sáez-Atienzar | R. Jorda | L. Bonet-Ponce | M. Tan | Connor Edsall | A. Jiménez-Escrig | J. Duarte | F. Vives | R. Durán | P. Mir | Marta Bonilla Toribio | Antonio Sanchez Rodriguez | E. Martín | M. J. G. Heredia | F. Errazquin | I. M. Torres | A. L. de Munain | M. Fernández | O. Dols-Icardo | P. Garcia-Ruiz | R. Duran | D. Buiza‐Rueda | Clara Ruz | J. Kim | I. Bernal-Bernal | M. G. Heredia | C. Méndez-del-Barrio | C. Tejera-Parrado | L. Vargas-González | I. González‐Aramburu | J. Simón-Sánchez | I. Bernal‐Bernal | L. Vargas‐González | Luis Bonet-Ponce | Marta Bonilla‐Toribio | M. Tan | J. Martínez-Castrillo | P. Pastor
[1] Nicholas J. Horton,et al. Using R and RStudio for Data Management, Statistical Analysis, and Graphics , 2015 .
[2] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.
[3] M. Peters,et al. Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.
[4] M. Polymeropoulos,et al. Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson’s disease , 1998, Human Genetics.
[5] P. Stenson,et al. Human Gene Mutation Database: towards a comprehensive central mutation database , 2007, Journal of Medical Genetics.
[6] Sonja W. Scholz,et al. Structural genomic variation in ischemic stroke , 2008, Neurogenetics.
[7] I. Alonso,et al. Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD , 2016, Neurology: Genetics.
[8] Sonja W. Scholz,et al. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases , 2017, Neurobiology of Aging.
[9] Sonja W. Scholz,et al. Parkinson disease age of onset GWAS: defining heritability, genetic loci and a-synuclein mechanisms , 2018, bioRxiv.
[10] M. Nalls,et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci , 2017, Nature Genetics.
[11] Tom R. Gaunt,et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.
[12] Simon C. Potter,et al. Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease , 2017, Brain : a journal of neurology.
[13] P. Visscher,et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.
[14] Ran Gilad-Bachrach,et al. DART: Dropouts meet Multiple Additive Regression Trees , 2015, AISTATS.
[15] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[16] Sina A. Gharib,et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood , 2018, Nature Communications.
[17] J. Obeso,et al. Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population , 2018, Neurobiology of Aging.
[18] Christopher R. Gignoux,et al. Gene flow from North Africa contributes to differential human genetic diversity in southern Europe , 2013, Proceedings of the National Academy of Sciences.
[19] Sonja W. Scholz,et al. Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk , 2018, bioRxiv.
[20] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[21] E. Tolosa,et al. Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism , 2002, Journal of neurology, neurosurgery, and psychiatry.
[22] F. Morón,et al. Genetic Structure of the Spanish Population , 2010, BMC Genomics.
[23] E. Topol,et al. The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.
[24] Xiaowei Zhan,et al. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data , 2016, Bioinform..
[25] Sonja W. Scholz,et al. Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk , 2018 .
[26] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[27] Pablo Mir,et al. Systematic mutational analysis of FBXO7 in a Parkinson's disease population from southern Spain , 2014, Neurobiology of Aging.
[28] E. Tolosa,et al. Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene , 2001, Annals of neurology.
[29] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[30] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.
[31] Yongtao Guan. Detecting Structure of Haplotypes and Local Ancestry , 2014, Genetics.
[32] Annie Niehaus,et al. Using ClinVar as a Resource to Support Variant Interpretation , 2016, Current protocols in human genetics.
[33] A. Singleton,et al. Genetic risk factors in Parkinson’s disease , 2018, Cell and Tissue Research.
[34] Jack Euesden,et al. PRSice: Polygenic Risk Score software , 2014, Bioinform..